£144.99

This is the most expensive it has ever been. Walk away.

£145 today · previous high £145 · all-time low £126

Elsevier Adenosine A2A Receptor Antagonists: Volume 170 (International Review of Neurobiology, Volume 170)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 61 days · 61 data points (no recent data)

Historical
Generating forecast…
£144.99 £123.98 £128.56 £133.15 £137.73 £142.32 £146.90 01 August 2026 16 August 2026 31 August 2026 15 September 2026 30 September 2026
View at Amazon ↗

Price data last checked 26 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 61 days • 2 price levels

Days at Price
Current Price
59 days 2 days · current 0 15 30 44 59 £126 £145 Days at Price

Price Analysis

Most common price: £126 (59 days, 96.7%)

Price range: £126 - £145

Price levels: 2 different prices over 61 days

Description

Adenosine A2A Receptor Antagonists, Volume 170 in the International Review of Neurobiology series highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including A2A Adenosine Receptor Agonists, Antagonists, Inverse Agonists and Partial Agonist, Chemistry – agonists, antagonists, partial agonists, inverse agonists, Functional roles of adenosine receptors – biochemistry and neuronal plasticity, A2A and Depression, A2AR and glial function, The adenosine A2A receptor in the basal ganglia: expression in health and disease, heteromerization, functional selectivity and signaling, How and why A2a receptor become to be a therapeutic target in Parkinson’s disease therapy, and much more. Provides the authority and expertise of leading contributors from an international board of authors Presents the latest release in the International Review of Neurobiology Updated release includes the latest information on Adenosine A2A Receptor Antagonists

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
22 September 2023
Listed Since
24 January 2023

Barcode

No barcode data available

Similar Products You Might Like

Non-pharmacological Interventions for Age-Related Neuropsychiatric Disorders: Volume 298 (Progress in Brain Research, Volume 298)
97% match

Non-pharmacological Interventions for Age-Related Neuropsychiatric Disorders: Volume 298 (Progress in Brain Research, Volume 298)

Elsevier

£183.59 03 Oct 2026
International Review of Neurobiology: 42: Volume 42
97% match

International Review of Neurobiology: 42: Volume 42

Elsevier

£101.49 01 Oct 2026
Synaptogenesis in the Mammalian Central Inhibitory Synapse: Mechanisms of Neuroligin Function in Inhibitory Postsynaptic Differentiation
97% match

Synaptogenesis in the Mammalian Central Inhibitory Synapse: Mechanisms of Neuroligin Function in Inhibitory Postsynaptic Differentiation

Südwestdeutscher Verlag für Hochschulschriften

£76.00 22 Sep 2026
Academic Press Neuropathic Pain - International Review Vol 179
97% match

Academic Press Neuropathic Pain - International Review Vol 179

Elsevier

£139.99 02 Oct 2026
Academic Press - International Review of Neurobiology Vol 62
97% match

Academic Press - International Review of Neurobiology Vol 62

Elsevier

£145.00 02 Oct 2026
Targeting Enzymes in the Brain: Volume 102 (Advances in Pharmacology, Volume 102)
97% match

Targeting Enzymes in the Brain: Volume 102 (Advances in Pharmacology, Volume 102)

Elsevier

£162.33 19 Sep 2026
Neurophysiology of Silence Part A: Empirical Studies (Volume 277) (Progress in Brain Research, Volume 277)
97% match

Neurophysiology of Silence Part A: Empirical Studies (Volume 277) (Progress in Brain Research, Volume 277)

Elsevier

£168.37 24 Sep 2026
Routledge Cognitive and Affective Neuroscience and Neurobiology
97% match

Routledge Cognitive and Affective Neuroscience and Neurobiology

Routledge

£151.26 02 Oct 2026
Medical Image and Signal Analysis in Brain Research: Volume 290 (Progress in Brain Research, Volume 290)
97% match

Medical Image and Signal Analysis in Brain Research: Volume 290 (Progress in Brain Research, Volume 290)

Elsevier

£170.49 27 Aug 2026
Methods for Preclinical Research in Addiction: 174 (Neuromethods, 174)
97% match

Methods for Preclinical Research in Addiction: 174 (Neuromethods, 174)

Humana

£100.33 24 Sep 2026
Neuroscience Without Representations: Building a Brain-in-a-World View
97% match

Neuroscience Without Representations: Building a Brain-in-a-World View

Elsevier

£97.99 09 Sep 2026
Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B (Volume 172) (International Review of Neurobiology, Volume 172)
97% match

Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B (Volume 172) (International Review of Neurobiology, Volume 172)

Elsevier

£129.65 24 Sep 2026
Molecular events related to oxidative and nitrosative stress during brain aging, neurodegeneration and neurotrauma
97% match

Molecular events related to oxidative and nitrosative stress during brain aging, neurodegeneration and neurotrauma

GRIN Verlag

£62.50 19 Sep 2026
Metabolic and Degenerative Diseases of the Central Nervous System: Pathology, Biochemistry, and Genetics
97% match

Metabolic and Degenerative Diseases of the Central Nervous System: Pathology, Biochemistry, and Genetics

Elsevier

£107.18 17 Sep 2026
Brain Shuttle Peptides: Development and Applications: Volume 105 (Advances in Pharmacology, Volume 105)
97% match

Brain Shuttle Peptides: Development and Applications: Volume 105 (Advances in Pharmacology, Volume 105)

Elsevier

£177.00 24 Sep 2026
Cell and Gene Therapies for Neurologic Diseases (Volume 205) (Handbook of Clinical Neurology, Volume 205)
97% match

Cell and Gene Therapies for Neurologic Diseases (Volume 205) (Handbook of Clinical Neurology, Volume 205)

Elsevier

£178.17 12 Sep 2026
Investigating the dynamic role of fluctuations in ongoing activity in the human brain
97% match

Investigating the dynamic role of fluctuations in ongoing activity in the human brain

GRIN Verlag

£61.89 07 Sep 2026
Understanding Figures in Neuroscience Research: A Guide to Interpreting Graphs and Methods
97% match

Understanding Figures in Neuroscience Research: A Guide to Interpreting Graphs and Methods

Cambridge University Press

£96.45 12 Sep 2026
Clinical Application of Repurposed Drugs: Volume 207 (Progress in Molecular Biology and Translational Science, Volume 207)
97% match

Clinical Application of Repurposed Drugs: Volume 207 (Progress in Molecular Biology and Translational Science, Volume 207)

Elsevier

£118.99 30 Sep 2026
Cannabidiol in Neurology and Psychiatry (Volume 177) (International Review of Neurobiology, Volume 177)
97% match

Cannabidiol in Neurology and Psychiatry (Volume 177) (International Review of Neurobiology, Volume 177)

Elsevier

£134.59 24 Sep 2026
Advanced Topics in Neurological Disorders
97% match

Advanced Topics in Neurological Disorders

IntechOpen

£119.00 12 Sep 2026
Precision Medicine in Neurodegenerative Disorders: Part I (Volume 192) (Handbook of Clinical Neurology, Volume 192)
97% match

Precision Medicine in Neurodegenerative Disorders: Part I (Volume 192) (Handbook of Clinical Neurology, Volume 192)

Elsevier

£177.29 08 Sep 2026
Academic Press Brain Energy Metabolism in Alzheimers Vol 187
97% match

Academic Press Brain Energy Metabolism in Alzheimers Vol 187

Elsevier

£140.00 02 Oct 2026
Fundamentals of Brain and Behavior - Introduction to Human Neuroscience
97% match

Fundamentals of Brain and Behavior - Introduction to Human Neuroscience

Routledge

£152.33 03 Oct 2026